Cancer clinical trials in the region Normandie
143 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lymphoma
#NCT06006117
#2022-501810-77-00
B cell lymphoma
Marginal zone lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
3 or more
Monoclonal antibodies
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Centre Henri Becquerel (Rouen )
The Lymphoma Academic Research Organisation (LYSARC)
Phase 3
Lung cancer
#NCT03774732
#2024-512173-27-00
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Locally Advanced
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
ALK
EGFR
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen)
UNICANCER
Phase 3
Kidney cancer
#NCT06364631
#2023-503317-29-00
Clear cell carcinoma
Metastatic
None
0
1 or 2
Systemic Treatment-Naive
Centre François Baclesse (Caen )
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Colon cancer
Rectal cancer
#NCT04120701
#2024-515297-27-00
Adenocarcinoma
Localized
Locally Advanced
None
Systemic Treatment-Naive
Surgery
Systemic Treatment-Naive
Surgery
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Rouen (Rouen), Centre Hospitalier Jacques Monod (Flers), Centre Hospitalier de Bayeux (Bayeux) (and 1 more...)
CHU Dijon
Phase 3
Breast cancer
#NCT05232916
#2023-504323-25-01
HER2 Positive
Localized
Locally Advanced
None
Targeted therapy
Targeted therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre François Baclesse (Caen )
Greenwich LifeSciences, Inc.
Phase 3
Lung cancer
#NCT06875310
#2024-515698-85-00
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
Targeted therapy
Targeted therapy
Centre François Baclesse (Caen )
Mirati Thérapeutique Inc.
Phase 3
Breast cancer
#NCT05696626
#2023-503708-10-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
1
2
Targeted therapy
Hormone therapy
Other mutation
Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Henri Becquerel (Rouen )
Sermonix Pharmaceuticals Inc.
Phase 3
Prostate cancer
#NCT05974774
#2023-506817-23-01
Metastatic Hormone-sensitive
None
Hormone therapy
Centre François Baclesse (Caen )
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3
Breast cancer
#NCT04862663
#2023-504997-39-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
Hormone therapy
Centre Hospitalier Universitaire de Rouen (Rouen)
AstraZeneca
Phase 3
Prostate cancer
#NCT06276465
#2023-507482-26-00
Adenocarcinoma
Metastatic Castration-resistant
None
Surgery
Radiotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Centre François Baclesse (Caen )
UNICANCER